Background: No risk factor has been confirmed for para-aortic lymph node (PAN) metastasis from gastric cancer. To identify the risk factors and the most frequent route of metastasis to PAN, we analyzed the prospective data from a phase III trial. Methods: In JCOG9501 comparing D2 and D2 þ PAN dissection, 260 patients with T2(SS)-T4 gastric cancer underwent radical gastrectomy with PAN dissection. The association between various clinicopathological factors and PAN metastasis was examined. Results: Macroscopic N stage and tumor size 5 cm were significant risk factors for PAN metastasis after adjusting for other factors. The proportion of PAN metastasis was clearly different between the N0 -1 group and the N2 -4 group (2.8% versus 20.5%). In the additional multivariate analysis including 17 regional lymph node stations, station No. 7 was the only station with statistical significance (P ¼ 0.002, odds ratio ¼ 41.0). Conclusion: Macroscopic N stage and tumor size were associated with PAN metastasis, and the lymphatics along the left gastric artery seemed to be the most frequent route to the nodes surrounding the aorta. These findings may be useful in predicting PAN metastasis.
INTRODUCTION
Most of the lymphatic flow from the stomach runs into the para-aortic lymph nodes (PAN), which are located above and below the left renal vein, before it flows into the cisterna chyli lying posterior to the aorta (1, 2) . Although the lymphatic flow is thought to reach the PAN through several routes (3, 4) , it is unclear which route is the most frequent access to PAN. In addition, the clinicopathological risk factors to predict metastasis to PAN have been unknown due to selection bias and contamination in surgically PAN positive patients in the majority of retrospective analyses.
In Japan, the regional lymph nodes of the stomach are generally classified into stations numbered as in Fig. 1 (5) . According to the 12th Edition of the Japanese General Rules for the Gastric Cancer Study (GRGCS) (6) , the lymph node metastasis of gastric cancer was classified into four categories (N1, N2, N3 and N4) ( Table 1 , Fig. 1 ). Metastasis to PAN belonged to N4, while it is grouped into distant metastasis (M1) in the TNM classification (7) . In Japan, the extended lymphadenectomy including N1 and N2 categories, known as D2, has been accepted as a standard surgical procedure for gastric cancer (8, 9) , and more radical surgery with extended para-aortic lymph node dissection (PAND) has been practiced to improve the survival for advanced gastric cancer in some specialized centers (10 -13) . Because PAND was controversial, a randomized controlled trial, the Japan Clinical Oncology Group Study 9501, was launched in 1995 to explore the potential survival benefit of D2 plus PAND over D2 dissection.
In the present study, we focused on 260 gastric cancer patients in the experimental treatment arm of JCOG9501 who underwent curative gastrectomy with D2 plus PAND, to identify the risk factors for PAN metastasis and the most likely route of metastasis to PAN.
PATIENTS AND METHODS
We used data obtained from the JCOG9501 study. The details of this phase III trial have been described elsewhere (14) . Briefly, the eligibility criteria were histologically proven adenocarcinoma of the stomach, T2(subserosa)-T4, M0, no macroscopic metastasis to the PAN, negative lavage cytology, adequate organ function, and age 75 years. Linitis plastica ('Bormann type 4') was excluded. All of the patients gave written informed consent to the study. Randomization and data handling were performed by the JCOG Data Center, a government-sponsored organization to perform multicenter clinical trials. Approval of the institutional review board was obtained at all participating institutions. The 24 institutions belonging to the Gastric Cancer Surgical Study Group of the JCOG participated in the trial.
From June 1995 to April 2001, 523 gastric cancer patients were randomized, and 260 patients were assigned to an experimental treatment arm and underwent D2 plus PAND surgery. In this group, PAN were dissected from the level of the celiac trunk down to the root of the inferior mesenteric artery (stations No. 16a2 and No. 16b1).
All the data were recorded according to the 12th Edition of the GRGCS (6) which was available at the start of the study. Although the 13th Edition (1998) with new nodal classification (N1 -N3) is currently available (5), we used the original data description in the present study.
The clinicopathological parameters that could be identified pre-or intra-operatively to decide the indication for PAND were compared between patients with and without PAN metastasis. The Fisher's exact test or x 2 test were used to assess the differences in proportion. To assess the association of various factors with PAN metastasis, multivariate logistic regression analysis was used with backward elimination procedure for variable selection with a ¼ 0.20. Next, the association between the histological status of 17 regional lymph node stations and the proportion of PAN metastatis were evaluated with odds ratio. In addition, to assess the relative strength of the association between lymph nodes and the PAN metastasis, all the 17 nodal stations were included in the multivariate logistic regression with backward elimination procedure for variable selection with a ¼ 0.20. (5)) (please note that a colour version of this figure is available as supplementary data at http://www.jjco.oxford journals.org). *Categories of the regional lymph nodes were classified according to the 12th Edition of the Japanese General Rules for Gastric Cancer Study (6) .
430 Para-aortic lymph node metastasis of gastric cancer Two-sided P values were calculated and are presented. Statistical analysis was performed using SAS version 8.12 software (SA5 Institute, Tokyo, Japan). In order to validate reproducibility of the predictive factors detected in this prospective study, we analyzed a retrospectively collected data set consisting of 158 patients who had undergone gastrectomy with PAND at Osaka Medical College between 1978 and 1999.
RESULTS
The patients ranged in age from 27 to 75 years (mean age, 61.0 years) and included 182 men and 78 women. In 47 of the 260 patients, the tumor was located in the upper third of the stomach, while it was in the middle third in 103 and the lower third in 110. Total gastrectomy was performed in 97 patients, distal gastrectomy in 160, and proximal gastrectomy in three.
PAN metastasis was histologically found in 22 (8.3%) of 260 patients. The association between the possible risk factors and PAN metastasis is shown in Table 2 . Tumor size 5 cm, undifferentiated type of histology, and macroscropic N2 -4 stage at surgery showed significant association in univariate analysis. After adjustment of other variables, macroscopic N stage and tumor size showed statistically significant association. The proportion of PAN metastasis stratified with macroscopic N stage is shown in Table 3 .
There were no significant associations in sex, body mass index, macroscopic tumor type, tumor location or macroscopic T stage.
In the independent data set from Osaka Medical College, the above results were reproduced; in macroscopically N0/ N1 cases, PAN metastasis was found in 1.6% (1/64), while in macroscopically N2 or N3/4, PAN metastasis was found in 9.8% (6/61) and 42.4% (14/33), respectively (Table 3) .
We next examined the associations between the histological status of 17 regional lymph node stations and PAN metastasis (Table 4) . Most nodal stations except for those along the greater curvature of the stomach (No. 2, 4sa, 4sb, 10) and No. 13, had significant association with PAN 
DISCUSSION
In the present study, the incidence of PAN metastasis was significantly higher in patients with undifferentiated tumor, large tumor and tumor with macroscopic N2 -4. Similar results have been reported in retrospective studies by other researchers (15, 16) . Among these factors, macroscopic N stage (P , 0.001) and tumor size 5 cm (P , 0.045) were significant risk factors for PAN metastasis after adjusting for other variables. Only one tumor smaller than 5 cm had PAN metastasis, while 12.5% of larger tumors had metastasis. This finding also helps us to study the pattern of lymphatic flow to the nodes surrounding the abdominal aorta. Lymphatic flow is thought to reach the para-aortic nodes via the following possible routes: (i) directly from the left para-cardial lymph nodes, (ii) from the lymph nodes along the splenic artery, (iii) from the lymph nodes around the celiac artery, (iv) from the lymph nodes along the superior mesenteric artery, and (v) from the lymph nodes on the posterior surface of the pancreatic head and the nodes along the posterior common hepatic artery (3, 4) . In this study, 15 of the 22 patients with PAN metastasis had involvement of lymph node No. 7, which is located by the celiac trunk. This suggests that the most likely route for PAN metastasis is from the left gastric artery nodes passing by the celiac artery.
JCOG9501 had superior quality control of surgical procedures and should provide more reliable data than previous retrospective studies. This also provides us with reliable information about metastasis to PAN, although the number of patients with PAN metastasis was not large (n ¼ 22). The possible survival impact of PAND should be clarified in further analyses.
In conclusion, this study indicated that macrosocpic N staging and tumor size 5 cm were important and independent risk factors for PAN metastasis, and that the lymphatics accompanying the celiac artery seem to be the most frequent route for metastasis to PAN. Station No. 7 was the most diagnostic lymph node for indicating the status of PAN.
